Interview with Rob Bootle: Advancements in Nanopharm’s OINDPs
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/ConversationsWithAnAptarPharmaExpert.jpg)
Join Rob Bootle as he explores his journey at Nanopharm, highlighting the company’s cutting-edge research and development in orally inhaled and nasal drug products (OINDPs).
Nanopharm Newsletter May 2023
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Explore Nanopharm’s SmartTrack™ for OINDPs and uncover the role of PBPK in nasal drug delivery.
Alternative regulatory path for generic Respiratory Products
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/Brochure-956x667-4.png)
Explore Nanopharm’s SmartTrack, an alternative solution for FDA approval of generic inhalation drug delivery products.
Trade Marks Registration Certificate for Nanopharm Ltd
![](https://nanopharm.co.uk/wp-content/uploads/2023/07/Nanopharmlogo.png)
Discover Nanopharm’s leading role in pharmaceutical research, specializing in OINDP, nasal, and inhaled pharmaceutical solutions.